News | May 25, 2010

Self-Expanding Drug-Eluting Stent Receives CE Mark


May 25, 2010 – A self-expanding, drug-eluting stent (DES) that just gained CE mark clearance in Europe is designed to ensure optimal apposition in the initial hours and days after an acute myocardial infarction (AMI) procedure.

The Stentys DES continuously applies pressure to the vessel wall, even during thrombus resolution and vessel spasm, which helps avoid malapposition, a major cause of stent thrombosis.

For more information: www.stentys.com


Additional Content

News | Stents

Nov. 24, 2025 — InspireMD, Inc., developer of the CGuard Prime carotid stent system for the prevention of stroke ...

Home November 24, 2025
Home
News | Stents

Oct. 13, 2025 — Medtronic plc recently announced it has received U.S. Food and Drug Administration (FDA) labeling ...

Home October 13, 2025
Home
News | Stents

Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial ...

Home October 16, 2024
Home
News | Stents

June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...

Home June 12, 2024
Home
News | Stents

June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and ...

Home June 04, 2024
Home
Subscribe Now